Revance Therapeutics, Inc.【RVNC】 資本金及び資本剰余金の推移

(単位:ドル) 資本金及び資本剰余金 前年比(%)
3Q24 105,000 +19.3%
2Q24 105,000 +19.3%
1Q24 104,000 +23.8%
4Q23 88,000 +7.3%
3Q23 88,000 +7.3%
2Q23 88,000 +20.5%
1Q23 84,000 +16.7%
4Q22 82,000 +13.9%
3Q22 82,000 +13.9%
2Q22 73,000 +1.4%
1Q22 72,000 +1.4%
4Q21 72,000 +4.3%
3Q21 72,000 +7.5%
2Q21 72,000 +26.3%
1Q21 71,000 +24.6%
4Q20 69,000 +32.7%
3Q20 67,000 +52.3%
2Q20 57,000 +29.5%
1Q20 57,000 +29.5%
4Q19 52,000 +40.5%
3Q19 44,000 +18.9%
2Q19 44,000 +18.9%
1Q19 44,000 +18.9%
4Q18 37,000 0.0%
3Q18 37,000 +19.4%
2Q18 37,000 +23.3%
1Q18 37,000 +23.3%
4Q17 37,000 +27.6%
3Q17 31,000 +6.9%
2Q17 30,000 +7.1%
1Q17 30,000 +7.1%
4Q16 29,000 +3.6%
3Q16 29,000 +20.8%
2Q16 28,000 +16.7%
1Q16 28,000 +16.7%
4Q15 28,000 +16.7%
3Q15 24,000 0.0%
2Q15 24,000 +4.3%
1Q15 24,000 +26.3%
4Q14 24,000 -
3Q14 24,000 -
2Q14 23,000 -
1Q14 19,000 -